NCT03210038

Brief Summary

Women arriving to the Urology department outpatient clinic at Assaf-Harofeh Medical Center in order to undergo a cystoscopy examination will be recruited. Patients will be randomly assigned to one of four groups by method of cystoscopy (flexible and rigid) and by use of anesthesia to the introitus. Pain levels will be recorded prior to the examination, during entrance of the cystoscope in the urethral meatus, immediately after the examination and 15 minutes after conclusion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 21, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 6, 2017

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

December 4, 2019

Status Verified

December 1, 2019

Enrollment Period

2.8 years

First QC Date

May 21, 2017

Last Update Submit

December 3, 2019

Conditions

Keywords

Cystoscopy

Outcome Measures

Primary Outcomes (4)

  • Pain before procedure

    Pain measurement using a 0-10 visual analogue scale (VAS) and comparison of average pain score between the four study groups.

    Before cystoscopy

  • Pain during meatus insertion of cystoscope

    Pain measurement using a 0-10 visual analogue scale (VAS) and comparison of average pain score between the four study groups.

    During the procedure, at the moment of cystoscopy insertion through the urethra

  • Pain immediately after procedure

    Pain measurement using a 0-10 visual analogue scale (VAS) and comparison of average pain score between the four study groups.

    Immediately after withdrawal of the cystoscope from the urethra

  • Pain 15 minutes after procedure

    Pain measurement using a 0-10 visual analogue scale (VAS) and comparison of average pain score between the four study groups.

    15 minutes after end of procedure

Study Arms (4)

Rigid cystoscopy, water based gel on introitus

ACTIVE COMPARATOR

Rigid cystoscopy, Wolf 17FR. Pad soaked with water based gel put on introitus for 5 minutes prior to procedure.

Drug: Water

Rigid cystoscopy, esracain gel based on introitus

ACTIVE COMPARATOR

Rigid Cystoscopy, Wolf 17FR. Pad soaked with Esracain (Lidocaine) put on the introitus for 5 minutes prior to procedure.

Drug: Lidocaine

Flexible cystoscopy, water based gel on introitus

ACTIVE COMPARATOR

Flexible cystoscopy, Olympus 16FR. Pad soaked with water based gel put on introitus for 5 minutes prior to procedure.

Drug: Water

Flexible cystoscopy, Esracain gel based on introitus

ACTIVE COMPARATOR

Flexible cystoscopy, Olympus 16FR. Pad soaked with Esracain (Lidocaine) put on the introitus for 5 minutes prior to procedure.

Drug: Lidocaine

Interventions

Pad soaked with lidocaine gel (Esracaine) left on the introitus for 5 minutes

Flexible cystoscopy, Esracain gel based on introitusRigid cystoscopy, esracain gel based on introitus
WaterDRUG

Water based non-anesthetic lubricant gel left on the introitus for 5 minutes.

Flexible cystoscopy, water based gel on introitusRigid cystoscopy, water based gel on introitus

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All women referred to elective outpatient cystoscopy.

You may not qualify if:

  • Known urethral stricture.
  • Known allergy to lubricant/anesthesia gel.
  • Patients under the age of 18 (minors).
  • Patients with current Urinary Tract Infections.
  • Chronic pelvic pain (e.g Interstitial Cystitis/Bladder Pain Syndrome.
  • Known neurlogical or other chronic pain syndrome requiring chronic analgesia medication.
  • Mentally incapable for consensual agreement of participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assaf Harofe Medical Center

Be’er Ya‘aqov, 70300, Israel

Location

Related Publications (4)

  • Aaronson DS, Walsh TJ, Smith JF, Davies BJ, Hsieh MH, Konety BR. Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain relief? BJU Int. 2009 Aug;104(4):506-9; discussion 509-10. doi: 10.1111/j.1464-410X.2009.08417.x. Epub 2009 Feb 23.

  • Patel AR, Jones JS, Babineau D. Lidocaine 2% gel versus plain lubricating gel for pain reduction during flexible cystoscopy: a meta-analysis of prospective, randomized, controlled trials. J Urol. 2008 Mar;179(3):986-90. doi: 10.1016/j.juro.2007.10.065. Epub 2008 Jan 18.

  • Seklehner S, Remzi M, Fajkovic H, Saratlija-Novakovic Z, Skopek M, Resch I, Duvnjak M, Hruby S, Librenjak D, Hubner W, Breinl E, Riedl C, Engelhardt PF. Prospective multi-institutional study analyzing pain perception of flexible and rigid cystoscopy in men. Urology. 2015 Apr;85(4):737-41. doi: 10.1016/j.urology.2015.01.007.

  • Stav K, Ohlgisser R, Siegel YI, Beberashvili I, Padoa A, Zisman A. Pain during Female Urethral Catheterization: Intraurethral Lubricant Injection versus Catheter Tip Lubrication--A Prospective Randomized Trial. J Urol. 2015 Oct;194(4):1018-21. doi: 10.1016/j.juro.2015.03.097. Epub 2015 Mar 25.

MeSH Terms

Conditions

HematuriaDysuriaUrinary Tract Infections

Interventions

LidocaineWater

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsInfections

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesHydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Pain assessment 4 randomly assigned groups of women divided by type of cystoscope and type of local anesthesia.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Urologist

Study Record Dates

First Submitted

May 21, 2017

First Posted

July 6, 2017

Study Start

March 1, 2017

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

December 4, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will share

IPD data includes age, BMI, previous medical, urological information. Pain levels during different stages of cystoscopy will be recorded.

Locations